BiondVax Announces Upcoming Investor Events: Presenting at the LD Micro Conference in Los Angeles Following Investor non-deal Roadshow

Ness Ziona, Israel – November 4, 2015 – BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV, TASE: BVXV) announced today that the Company’s CEO, Dr. Ron Babecoff, will be meeting with US and Canadian investors on the week of November 9-13, 2015. Over the course of that week, Dr. Babecoff will be visiting New York, Boston, Chicago and Toronto.On December 2-3, 2015, Dr. Babecoff will be attending and presenting at the LD Micro Conference taking place at the Luxe Sunset Hotel in Los Angeles. This will provide investors located on the West Coast an opportunity to meet with management. Dr. Babecoff’s presentation is scheduled for Thursday, December 3, 2015 at 8:30am Pacific Time.On both the roadshow and the LD Micro conference there will be an opportunity for investors to meet one-on-one with Dr. Babecoff. Investors interested in meeting with management should contact the Investor Relations team at BiondVax.The corporate presentation which will be used on the roadshow and at the conference is available for download from the investor relations section of BiondVax’s website at www.biondvax.com.

Previous
Previous

BiondVax Announces Third Quarter 2015 Financial Results and Update

Next
Next

BiondVax Announces Successful Recruitment of the First Participants in a Phase IIb Clinical Trial in Europe with its Universal Flu Vaccine: Multimeric M-001